Analyst Price Target is $363.75
▲ +12.14% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Abiomed in the last 3 months. The average price target is $363.75, with a high forecast of $425.00 and a low forecast of $245.00. The average price target represents a 12.14% upside from the last price of $324.36.
Current Consensus is
The current consensus among 4 contributing investment analysts is to hold stock in Abiomed. This Hold consensus rating has held steady for over two years.